Kanghua Bio: NanoRibo RSV Vaccine Enters Phase II Clinical Trial
May 29, 2026 18:30
CST Updated
18:57
Kangh
Biological Products Research and Development, Manufacturer
NanoRibo
mRNA New Vaccine and Drug Developer